Summary

• Study director: Bruce Miller, MD [1]
• Sponsor: California Institute for Regenerative Medicine (CIRM)
• Recruiting?: Yes
• Official study title: Establishment of Frontotemporal Dementia Patient Induced Pluripotent Stem (iPS) Cell Lines
• Conditions studied: Frontotemporal dementia (FTD) [2], Alzheimer's disease (AD) [3] and other closely related neurological disorders including corticobasal degeneration (CBD) [4], progressive supranuclear palsy (PSP) [5] and amyotrophic lateral sclerosis (ALS) with dementia [6]
• Purpose: The purpose of this study is to study the disease-causing mechanisms of frontotemporal dementia (FTD) and create models to study neurological diseases for which there are not adequate human in vitro or animal models.